Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study ; volume:38 ; number:5 ; day:9 ; month:4 ; year:2021 ; pages:2558-2570 ; date:5.2021
Advances in therapy ; 38, Heft 5 (9.4.2021), 2558-2570, 5.2021
- Creator
-
Bergman, Martin
Zhou, Lili
Patel, Pankaj
Sawant, Ruta
Clewell, Jerry
Tundia, Namita
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-021-01730-w
- URN
-
urn:nbn:de:101:1-2021091118513062423085
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bergman, Martin
- Zhou, Lili
- Patel, Pankaj
- Sawant, Ruta
- Clewell, Jerry
- Tundia, Namita
- SpringerLink (Online service)
Other Objects (12)
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis
Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review
Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis - a systematic review of the literature
Rheumatoid arthritis
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis
Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review
Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis - a systematic review of the literature
Rheumatoid arthritis
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
Administration costs of intravenous biologic drugs for rheumatoid arthritis
The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis
Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review
Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis - a systematic review of the literature